Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN86632774Phase 2Completed
Phase 2, randomised, double-blind trial in rotaviral diarrhea comparing RIX4414 plus placebo schedule with Placebo control (2 arms). Primary endpoints: Anti-poliovirus type 1 seroprotection, Anti-poliovirus type 2 seroprotection and 1 more. Started Jan 2001; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN86632774.